Can Phase III Trial Results of Antidepressant Medications Be Generalized to Clinical Practice? A STAR*D Report

Cited by (223)

Items 101–200 of 223

1. Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and Concerns
   Daniel J. Safer, JULIE MAGNO ZITO · 2019 · Frontiers in Psychiatry
2. Practice-based psychotherapy research in a public health setting: Obstacles and opportunities.
   Jared A. DeFife, Rebecca L. Drill, Jack Beinashowitz, Lucinda Ballantyne, Dennis D. Plant, Lotte Smith-Hansen, Vincenzo G. Terán, Laura Werner-Larsen, Thomas Westerling, Yi‐Ching Yang et al. · 2015 · Journal of Psychotherapy Integration
3. From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings
   Konstantinos Ν. Fountoulakis, Roger S. McIntyre, Andre Ferrer Carvalho · 2015 · Current Neuropharmacology
4. Is placebo useful in the treatment of major depression in clinical practice?
   Carlo Marchesi, Chiara De Panfilis, Matteo Tonna, Paolo Ossola · 2013 · Neuropsychiatric Disease and Treatment
5. An electronic health record driven algorithm to identify incident antidepressant medication users
   William Victor Bobo, Jyotishman Pathak, Hilal Maradit Kremers, Barbara P. Yawn, Scott M. Brue, Cynthia J. Stoppel, Paul E. Croarkin, Jennifer L. St. Sauver, Mark A. Frye, W. A. Rocca · 2014 · Journal of the American Medical Informatics Association
6. Clinical Necessity Guidelines for Psychotherapy, Insurance Medical Necessity and Utilization Review Protocols, and Mental Health Parity
   Susan G. Lazar, Meiram Bendat, Glen O. Gabbard, Kenneth N. Levy, Nancy McWilliams, Eric M. Plakun, Jonathan Shedler, Frank E. Yeomans · 2018 · Journal of Psychiatric Practice
7. Usefulness of Symptom Feedback to Providers in an Integrated Primary Care-Mental Health Care Clinic
   Lisa Zubkoff, Yinong Young‐Xu, Brian R. Shiner, Andy Pomerantz, Bradley Vincent Watts · 2012 · Psychiatric Services
8. Functional Impairment and Changes in Depression Subtypes for Women in STAR*D: A Latent Transition Analysis
   Christine M. Ulbricht, Anthony J. Rothschild, Kate L. Lapane · 2015 · Journal of Women s Health
9. Generalizability of Findings From Efficacy Trials for Chronic Depression: An Analysis of Eligibility Criteria
   Alessa von Wolff, Malte Jansen, Lars P. Hölzel, Annika Westphal, Martin Christian Härter, Levente Kriston · 2014 · Psychiatric Services
10. Adherence to guidelines and effectiveness of inpatient treatment for unipolar depression
    Stephan Köhler, Sabine Hoffmann, Theresa Unger, Bruno Steinacher, Thomas Fydrich · 2011 · International Journal of Psychiatry in Clinical Practice
11. Baseline characteristics of a European patient population with difficult-to-treat depression (RESTORE-LIFE) treated with adjunctive vagus nerve stimulation
    Koen Demyttenaere, Tiago Costa, Erhan Kavakbasi, Mei Jiang, An Scheltens, Maxine Dibué, Beth Hall, Pablo Andrade, Hamish McAllister-Williams, Bernhard Theodor Baune et al. · 2023 · Journal of Affective Disorders
12. Psychotherapy and Psychosocial Treatment: Recent Advances and Future Directions.
    E. Plakun · 2015 · Psychiatric Clinics of North America
13. Influence of sociodemographic and socioeconomic features on treatment outcome in RCTs versus daily psychiatric practice
    Rosalind van der Lem, Purdey M. Stamsnieder, Nic J.A. van der Wee, Tineke van Veen, Frans G. Zitman · 2012 · Social Psychiatry and Psychiatric Epidemiology
14. Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression
    Emanuel Severus, Florian Seemüller, Michael Berger, Sandra Dittmann, Michael Obermeier, Andrea Pfennig, Michael J Riedel, Sophia Frangou, Hans‐Jürgen Möller, Michael Bauer · 2012 · BMC Medicine
15. Investigating the metabolic alterations in a depressive-like rat model of chronic forced swim stress: An in vivo proton magnetic resonance spectroscopy study at 7T
    Chi‐Hyeon Yoo, Song‐I Lim, Kyu-Ho Song, Dong‐Cheol Woo, Bo‐Young Choe · 2018 · Neurochemistry International
16. Can electronic health records revive central nervous system clinical trials?
    Roy H. Perlis, Maurizio Fava M. D, Thomas H. McCoy · 2018 · Molecular Psychiatry
17. Narrowing the Gaps Between What We Know and What We Do in Psychiatry
    Augustus John Rush · 2015 · The Journal of Clinical Psychiatry
18. The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years
    Mark A. Zimmerman, Carolina Guzman Holst, Heather Clark, Matthew D. Multach, Emily K. Walsh, Lia K. Rosenstein, Douglas Gazarian · 2016 · CNS Drugs
19. Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorder
    Eduard Vieta, Michael Bauer, Stuart Montgomery, Roger S. McIntyre, Johan Szamosi, Willie R. Earley, Hans Eriksson · 2013 · Journal of Affective Disorders
20. Psychotherapy and Pharmacotherapy: A Contemporary Perspective
    Larry S. Sandberg, Fredric N. Busch · 2012 · Psychodynamic Psychiatry
21. Applying the inclusion/exclusion criteria in placebo-controlled studies to a clinical sample: A comparison of medications
    Zimmerman, Mark, Balling, Caroline, Chelminski, Iwona, Dalrymple, Kristy · 2020 · Journal of Affective Disorders
22. Racial and Ethnic Disparities in Antihypertensive Medication Prescribing Patterns and Effectiveness
    Slavina B. Goleva, Ariel Williams, David J. Schlueter, Jacob M. Keaton, Tam C. Tran, Bennett J. Waxse, Tracey M. Ferrara, Thomas A. Cassini, Huan Mo, Joshua C. Denny · 2024 · Clinical Pharmacology & Therapeutics
23. Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences
    Antoni Sicras‐Mainar, Ruth Navarro‐Artieda, Milagrosa Blanca-Tamayo, Victoria Gimeno-de la Fuente, Jordi Salvatella-Pasant · 2010 · Current Medical Research and Opinion
24. Stakeholder engagement for comparative effectiveness research in cancer care: experience of the DEcIDE Cancer Consortium
    Caprice Christian Greenberg, Jennifer K. Wind, George J. Chang, R. C. Chen, Deborah Schrag · 2013 · Journal of Comparative Effectiveness Research
25. Understanding adverse drug reactions: An overview
    Mark Greener · 2014 · Nurse Prescribing
26. Outliers on the Dose-Response Curve: How to Minimize This Problem Using Therapeutic Drug Monitoring, an Underutilized Tool in Psychiatry
    Sheldon Preskorn · 2010 · Journal of Psychiatric Practice
27. Co-Occurring Disorders and Treatment Complexity Within Personality Disorders
    James Christopher Fowler, John M. Oldham · 2013 · FOCUS The Journal of Lifelong Learning in Psychiatry
28. Clinical judgement, case complexity and symptom scores as predictors of outcome in depression: an exploratory analysis
    Michael J. Smith, Bernard Francq, Alex McConnachie, Kirsty Wetherall, Anthony J. Pelosi, Joe Morrison · 2020 · BMC Psychiatry
29. Toward National Estimates of Effectiveness of Treatment for Substance Use
    Carlos Blanco, Aimee N. C. Campbell, Melanie M. Wall, Mark Olfson, Shuai Wang, Edward V. Nunes · 2017 · The Journal of Clinical Psychiatry
30. Variability in the substance use disorder exclusion criterion in antidepressant efficacy trials
    Mark A. Zimmerman, Heather Clark, Matthew D. Multach, Emily K. Walsh, Lia K. Rosenstein, Douglas Gazarian · 2016 · Journal of Affective Disorders
31. Clinical Features and Outcomes of 124 Italian Patients With Treatment Resistant Depression: A Real-World, Prospective Study
    Giulio Perugi, Paola Calò, Sergio De Filippis, Gianluca Rosso, Antonio Vita, Marina Adami, Giuseppe Ascione, Joachim Morrens, Dario Delmonte · 2021 · Frontiers in Psychiatry
32. Clinical Repetitive Transcranial Magnetic Stimulation for Veterans with Major Depressive Disorder
    F. Kozel, Michael J. Hernandez, Kimberly Van Trees, S. Phillips, Jaffrey Hashimie, Mark Weisman, Demian F. Obregon, Deborah L. Sanchez, G. Catalano, S. K. Schultz · 2017 · Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
33. Electroconvulsive Therapy for Patients With Depression Who Lack Capacity for Consent
    Akihiro Takamiya, Filip Bouckaert, Pascal A. Sienaert, Takahito Uchida, Shun Kudo, Bun Yamagata, Taishiro Kishimoto, Masaru Mimura, Jinichi Hirano · 2021 · Journal of Ect
34. Do we need more than one antidepressant for patients with major depressive disorder?
    Chi‐Un Pae, Changsu Han, Tae‐Youn Jun · 2011 · Expert Review of Neurotherapeutics
35. Bringing Evidence to Bear on Public Health in the United States
    Kevin M. Callahan, Elizabeth A. Stuart · 2018 · Public Health Reports
36. The Effectiveness of Antidepressant Monotherapy in a Naturalistic Outpatient Setting
    Tih-Shih W. Lee, Pryseley Nkouibert Assam, Kenneth R. Gersing, Edwin Chan, Bruce M. Burchett, Kang Sim, Lei Feng, K. Ranga Krishnan, Augustus John Rush · 2012 · The Primary Care Companion For CNS Disorders
37. Psychodynamic Systems of Residential Treatment: Another View From Riggs
    Spencer Biel, Eric M. Plakun · 2015 · Psychodynamic Psychiatry
38. Problems in the Descriptions of the Psychiatric Inclusion and Exclusion Criteria in Publications of Antidepressant Efficacy Trials: A Qualitative Review and Recommendations for Improved Clarity
    Mark Zimmerman, Matthew D. Multach, Emily K. Walsh, Lia K. Rosenstein, Douglas Gazarian, Heather Clark · 2016 · CNS Drugs
39. Repetitive Transcranial Magnetic Stimulation (5 and 10 Hz) With Modified Parameters in the Treatment of Resistant Unipolar and Bipolar Depression in a Private Practice Setting
    F. Rachid, C. Moeglin, O. Sentissi · 2017 · Journal of Psychiatric Practice
40. Learning the “Science of the Art of Prescribing”: From Evidence-based Algorithms to Individualized Medicine in Psychiatric Care
    Ian King, Yakov Shapiro · 2022 · Journal of Psychiatric Practice
41. Active Postmarketing Drug Surveillance for Multiple Adverse Events
    Joel Goh, Margret V. Bjarnadottir, Mohsen Bayati, Stefanos A. Zenios · 2015 · Operations Research
42. Clinical and sociodemographic features of the Texas resilience against depression (T-RAD) study: Findings from the initial cohort
    Madhukar H. Trivedi, Manish K. Jha, Joshua S. Elmore, Thomas James Carmody, Cherise Chin Fatt, Sangita Sethuram, Tianyi Wang, Taryn L. Mayes, Jane Allyson Foster, Abu Minhajuddin · 2024 · Journal of Affective Disorders
43. A systematic review of the characteristics of adolescents with major depressive disorder in randomised controlled treatment trials
    Amy McCulloch, Leo Kroll, James Glass, Bernadka Dubicka · 2021 · The European Journal of Psychiatry
44. Uso de la farmacogenética como herramienta de precisión en psiquiatría: hacia una medicina personalizada
    Wielandt N. Ana María, Moreno C. Mauricio, Ortiz L. Lina · 2022 · Revista Médica Clínica Las Condes
45. Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labeling
    Mark Zimmerman, Heather Clark, Matthew D. Multach, Emily K. Walsh, Lia K. Rosenstein, Douglas Gazarian · 2015 · Journal of Affective Disorders
46. Practical Clinical Trials in Psychopharmacology
    Benedetto Vitiello · 2015 · Journal of Clinical Psychopharmacology
47. Recovery From Comorbidity
    Mathew Carter, Colleen M. Fisher, Mohan Isaac · 2013 · SAGE Open
48. Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial
    José Manuel Menchón, Jordi Espadaler, Miquel Tuson, J. Sáiz‐Ruiz, Julio Bobes, Eduard Vieta, Enric Álvarez, Víctor Pérez · 2018 · Journal of Neural Transmission
49. Clinical and Insurance Perspectives on Intermediate Levels of Care in Psychiatry
    Eric M. Plakun · 2018 · Journal of Psychiatric Practice
50. Dimensions and Predictors of Personal Recovery in Major Depression
    Mario Luciano, Claudia Carmassi, Umberto Albert · 2022 · Comprehensive approach to psychiatry
51. Off-label prescribing of antidepressants
    Daniel R. Morales, Bruce Guthrie · 2017 · BMJ
52. Inclusion/exclusion criteria in late life depression antidepressant efficacy trials
    Mark A. Zimmerman, Matthew D. Multach, Heather Clark, Emily K. Walsh, Lia K. Rosenstein, Douglas Gazarian · 2016 · International Journal of Geriatric Psychiatry
53. Persistent decrease in alpha current density in fully remitted subjects with major depressive disorder treated with fluoxetine: A prospective electric tomography study
    Luis Guillermo Almeida Montes, Hugo Prado Alcántara, Bertha Alicia Portillo Cedeño, Ana Olivia Hernández García, Patricia Elisa Fuentes Rojas · 2015 · International Journal of Psychophysiology
54. The Mental Health Crisis in America: Recognizing Problems; Working Toward Solutions: Part 1. Defining the Crisis
    Eric M. Plakun · 2020 · Journal of Psychiatric Practice
55. A Naturalistic Study of Time to Recovery in Adults with Treatment-refractory Disorders
    J. Perry, J. C. Fowler · 2021 · Psychiatry
56. Determining severity subtypes of depression with a self-report questionnaire
    Mark A. Zimmerman, Jennifer H. Martinez, Michael A. Friedman, Daniela A. Boerescu, Naureen Attiullah, Cristina Toba · 2012 · Psychiatry Research
57. Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study
    T. Hashimoto, Daiji Sakurai, Y. Oda, T. Hasegawa, N. Kanahara, Tsuyoshi Sasaki, Hideki Komatsu, Junpei Takahashi, Takahiro Oiwa, Y. Sekine et al. · 2015 · Neuropsychiatric Disease and Treatment
58. Metabolic effects of light deprivation in the prefrontal cortex of rats with depression-like behavior: In vivo proton magnetic resonance spectroscopy at 7T
    Chi‐Hyeon Yoo, Kyu-Ho Song, Song‐I Lim, Dong‐Cheol Woo, Bo‐Young Choe · 2018 · Brain Research
59. Psychiatry should not become hostage to placebo: An alternative interpretation of antidepressant–placebo differences in the treatment response in depression
    Zoltán Rihmer, Péter Döme, David S. Baldwin, Xénia Gonda · 2012 · European Neuropsychopharmacology
60. The potential role of Marginal Structural Models (MSMs) in testing the effectiveness of antidepressants in the treatment of patients with major depression in everyday clinical practice
    Emanuel Severus, Ilya A. Lipkovich, Florian Seemüller, Michael Obermeier, Heinz Grunze, Britta Bernhard, Sandra Dittmann, Michael J Riedel, Hans‐Jürgen Möller · 2011 · The World Journal of Biological Psychiatry
61. Trials Assessing Parmacotherapeutic Management of Aggression in Psychiatric Patients: Comparability with Clinical Practice
    Laurette E. Goedhard, Joost Jan Stolker, Henk L. I. Nijman, Toine C. G. Egberts, Eibert Roelof Heerdink · 2010 · Pharmacopsychiatry
62. The Lived Experience of College Sudents Who have Been Medicated with Antidepressants
    Pamela Aselton · 2022 · ScholarWorks@UMassAmherst (University of Massachusetts Amherst)
63. The FDA's failure to address the lack of generalisability of antidepressant efficacy trials in product labelling
    Mark A. Zimmerman · 2016 · The British Journal of Psychiatry
64. Novel approaches to drug-placebo difference calculation: evidence from short-term antidepressant drug-trials
    Zoltán Rihmer, Xénia Gonda, Péter Döme, Péter Erdős, Mihály Ormos, Luca Pani · 2011 · Human Psychopharmacology Clinical and Experimental
65. Anti-suicidal effects of IV ketamine in a real-world setting
    Brittany O’Brien, Jaehoon Lee, Seungman Kim, Guriqbal S. Nandra, Prabhneet Pannu, Amanda J. F. Tamman, Dania Y. Amarneh, Alan C. Swann, Nicholas Murphy, Lynnette A. Averill et al. · 2023 · Psychiatry Research
66. A Partially Randomized Patient Preference, Sequential, Multiple‐Assignment, Randomized Trial Design Analyzed via Weighted and Replicated Frequentist and Bayesian Methods
    Marianthie Wank, Sarah Medley, Roy Tamura, Thomas Braun, KM Kidwell · 2024 · Statistics in Medicine
67. Assessment of suicidal ideation and behavior in clinical trials: challenges and controversies
    Glenn Alexander Melvin, Michael S Gordon, Belinda M Freake · 2012 · Clinical Investigation
68. Detection of Suicidality Through Privacy-Preserving Large Language Models
    Isabella C. Wiest, Falk Gerrik Verhees, Dyke Ferber, Jiefu Zhu, Michael Bauer, Ute Lewitzka, Andrea Pfennig, Pavol Mikoláš, Jakob Nikolas Kather · 2024 · medRxiv
69. Psychodynamic Therapy: An Overview for Trainees and Their Teachers: Part 1–The Basics
    Eric M. Plakun · 2023 · Journal of Psychiatric Practice
70. Observational studies of antidepressant use and suicide risk are selectively published in psychiatric journals
    Martin Plöderl, Simone Amendola, Michael P. Hengartner · 2023 · Journal of Clinical Epidemiology
71. Targeting treatments for depression: what can our patients tell us?
    Augustus John Rush · 2016 · Epidemiology and Psychiatric Sciences
72. Addressing the unmet needs of current antidepressants: does neuroscience help or hinder clinical psychopharmacology research?
    Joseph F. Goldberg, Augustus John Rush · 2017 · Expert Opinion on Pharmacotherapy
73. SSRIs: exploring controversies, conundrums, and contentions—epiphenomenon or empirical ingenuity? A comparative panorama for untangling enigma in children and youths
    Mayank Gupta, Theodore A. Petti · 2025 · CNS Spectrums
74. Socio-demographic features of participants in randomized con-trolled trials for major depression: generalizability and individu-alization.
    Rosalind van der Lem, Purdey M. Stamsnieder, Nic J.A. van der Wee, Tineke van Veen, Frans G. Zitman · 2011 · The International Journal of Person Centered Medicine
75. Randomized Controlled Trials and the Efficacy of Psychotropic Medications
    Boadie Waid Dunlop, Carolina Medeiros da Frota Ribeiro · 2022 · Springer eBooks
76. Double-Blind Randomized Placebo-Controlled Trials in the Treatment of Affective Disorders: Problems and Alternatives
    Emanuel Severus, Eric B. Laber, Ilya A. Lipkovich · 2015 · Current Treatment Options in Psychiatry
77. Prescribing for depressed adolescents: Office decision‐making in the face of limited research evidence
    Michael Gordon, Glenn Alexander Melvin · 2014 · Journal of Paediatrics and Child Health
78. Improving the Care of Patients Who Have Treatment-Resistant Depression: The Promise of the PCORnet Mood Network
    Andrew Alan Nierenberg, Louisa G. Sylvia, Allen Doederlein, Susan Edgman‐Levitan, Alies Muskin, Lucinda Jewell, Muffy Walker, Dan Goodman, Massoud Farahbakhsh, Casey M. Hearing et al. · 2015 · The Journal of Clinical Psychiatry
79. Drug development: bench to bedside
    Mark Greener · 2010 · Nurse Prescribing
80. Clinical and Forensic Standards for the Psychological Assessment of Patients with Chronic Pain
    Daniel L. Bruns · 2014 · Psychological Injury and Law
81. Impact of Pretreatment With Antidepressants on the Efficacy of Duloxetine in Terms of Mood Symptoms and Functioning
    Bruno R. Barros, Alexander Schacht, Michael Happich, Foula Televantou, Lovisa Berggren, Daniel J. Walker, Héctor Dueñas · 2014 · The Primary Care Companion For CNS Disorders
82. Understanding the Antidepressant Debate in the Treatment of Major Depressive Disorder
    Florian Naudet, Rémy Boussageon, Clément Palpacuer, Laurent Gallet, Jean‐Michel Reymann, Bruno Falissard · 2015 · Therapies
83. Wirken Antidepressiva eigentlich?
    Tom Bschor · 2013 · NeuroTransmitter
84. 6. Generalizability of Clinical Trials Results
    Elizabeth A. Stuart · 2017 · CRC Press eBooks
85. A Novel Study Design to Systematically Explore the Impact of Trial Methodology on Psychopharmacological Treatment Outcome in Patients with Depression
    Emanuel Severus, Cathrin Sauer, Michael Bauer, Michael Joshua Ostacher, Ion‐George Anghelescu · 2018 · Pharmacopsychiatry
86. Improving the Care of Patients Who Have Treatment-Resistant Depression: The Promise of the PCORnet Mood Network
    Andrew Alan Nierenberg, Louisa G. Sylvia, Allen Doederlein, Susan Edgman‐Levitan, Alies Muskin, Lucinda Jewell, Muffy Walker, Dan Goodman, Massoud Farahbakhsh, Casey M. Hearing et al. · 2015 · The Journal of Clinical Psychiatry
87. Eligibility of emergency psychiatry patients for clinical trials studying depression
    Ryan E. Lawrence, Adam Bernstein, Chaya Jaffe, Yinjun Zhao, Yuanjia Wang, Terry E. Goldberg · 2023 · Journal of Affective Disorders
88. Evolution of Depressive Symptoms Among Depression Subtypes of Clinical and Functional Variables in Primary Care in Chile
    Veronica G. Vitriol, Alfredo Cancino, Catalina Bustamante, María de la Luz Aylwin · 2024 · Journal of Primary Care & Community Health
89. Stable remission of depression after antidepressant treatment: prevalence and related sociodemographic and clinical characteristics in a longitudinal, real-world cohort
    Mariska Bot, Suzanne A. Ligthart, Huibert Burger, Nina H. Grootendorst–van Mil, Ingrid A. Arnold, Sjoerd M. van Belkum, Pierre M. Bet, Tom K. Birkenhäger, Wilma Göttgens, Jacqueline Geertruida Hugtenburg et al. · 2025 · Journal of Affective Disorders
90. The nature of depression and the biomedical model: ten questions in search of an answer
    Konstantinos Ν. Fountoulakis · 2026 · Translational Psychiatry
91. Latent profiles of generative artificial intelligence use among Chinese college students: Associations with depression and anxiety
    Haoyang Shi, Tongyi Zhang, Zihao Wang, Xiaolong Yang, Zixuan Shao, Xiaofeng Ma · 2026 · Journal of Affective Disorders
92. Medical Test Development and Implementation: A Multistep Journey
    Augustus John Rush · 2015 · The Journal of Clinical Psychiatry
93. Depression in Clinical Practice
    MG Rabbani · 1970 · Bangladesh Medical Journal
94. Ketamine for Treatment-Resistant Depression: Ready or Not for Clinical Use?
    Augustus John Rush · 2014 · FOCUS The Journal of Lifelong Learning in Psychiatry
95. Research Article TRANSCRANIAL MAGNETIC STIMULATION (TMS) FOR MAJOR DEPRESSION: A MULTISITE, NATURALISTIC, OBSERVATIONAL STUDY OF ACUTE TREATMENT OUTCOMES IN CLINICAL PRACTICE
    Linda L. Carpenter, Philip G. Janicak, Scott T. Aaronson, Terrence A. Boyadjis, David G. Brock, Ian A. Cook, David L. Dünner, Karl I. Lanocha, H. Brent Solvason, Mark A. Demitrack · 2012
96. General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry Thomas C. BaghaiPierre BlierDavid S. BaldwinMichael Bauer • Guy M. GoodwinKostas N. FountoulakisSiegfried KasperBrian E. Leonard • Ulrik F. MaltDan SteinMarcio VersianiHans-Jurgen Moller • for the Section of Pharmacopsychiatry, World Psychiatric Association
    Thomas C. Baghai, Pierre Blier, David S. Baldwin, Michael Bauer, Konstantinos Ν. Fountoulakis, Siegfried F. Kasper, Brian E. Leonard, Dan Joseph Stein, Márcio Versiani · 2011
97. Randomized Controlled Trials and the Efficacy of Psychotropic Medications
    Boadie Waid Dunlop, Carolina Medeiros da Frota Ribeiro · 2019 · Springer eBooks
98. Calibrated meta-analysis to estimate the efficacy of mental health treatments in target populations: an application to paliperidone trials for treatment of schizophrenia
    Hwanhee Hong, Lu Liu, Ramin Mojtabai, Elizabeth A. Stuart · 2023 · BMC Medical Research Methodology
99. Aktuelle ethische Fragen in der Depressionsforschung
    Emanuel Severus, Michael Bauer · 2013 · Springer eBooks
100. Depresyon Tedavisinde Karşılanmamış İhtiyaçlar: Eştanılı Anksiyete ve Yaklaşım
     Nesrin Dılbaz, Aslı Enez Darçın, Serçin Yalçın Çavuş · 2011 · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology